|Year : 2020 | Volume
| Issue : 2 | Page : 60-67
Investigation of effect of tectorigenin (O-methylated isoflavone) on Ca2+ signal transduction and cytotoxic responses in canine renal tubular cells
He-Hsiung Cheng1, Wei-Zhe Liang2, Wei-Chuan Liao3, Chun-Chi Kuo4, Lyh-Jyh Hao5, Chiang-Ting Chou6, Chung-Ren Jan7
1 Department of Medicine, Chang Bing Show Chwan Memorial Hospital, Changhua County, Taiwan
2 Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung; Department of Pharmacy, Tajen University, Pingtung, Taiwan
3 Department of Surgery, Kaohsiung Veterans General Hospital; Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan
4 Department of Nursing, Tzu Hui Institute of Technology, Pingtung, Taiwan
5 Department of Endocrinology and Metabolism, Kaohsiung Veterans General Hospital Tainan Branch; Chung Hwa University of Medical Technology, Tainan, Taiwan
6 Department of Nursing, Division of Basic Medical Sciences, Chang Gung University of Science and Technology, Chiayi Campus; Division of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital Chiayi Branch, Puzi City, Chiayi County, Taiwan
7 Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
|Date of Submission||07-Feb-2020|
|Date of Acceptance||18-Mar-2020|
|Date of Web Publication||27-Apr-2020|
Dr. Chiang-Ting Chou
Department of Nursing, Division of Basic Medical Sciences, Chang Gung University of Science and Technology, Chiayi Campus, Puzi City, 61363, Chiayi County
Dr. Chung-Ren Jan
Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362
Dr. Lyh-Jyh Hao
Department of Endocrinology and Metabolism, Kaohsiung Veterans General Hospital Tainan Branch, Tainan 71051
Source of Support: This work was supported by RD.105001 from Chang Bing
Show Chwan Memorial Hospital, Changhua County 50544,
Taiwan., Conflict of Interest: None
Tectorigenin, a traditional Chinese medicine, is isolated from the flower of plants such as Pueraria thomsonii Benth. It is an O-methylated isoflavone, a type of flavonoid. Previous studies have shown that tectorigenin evoked various physiological responses in different models, but the effect of tectorigenin on cytosolic-free Ca2+ levels ([Ca2+]i) and cytotoxicity in renal tubular cells is unknown. Our research explored if tectorigenin changed Ca2+ signal transduction and viability in Madin–Darby Canine Kidney (MDCK) renal tubular cells. [Ca2+]i in suspended cells were measured by applying the fluorescent Ca2+-sensitive probe fura-2. Viability was explored by using water-soluble tetrazolium-1 as a fluorescent dye. Tectorigenin at concentrations of 5–50 μM induced [Ca2+]i rises. Ca2+ removal reduced the signal by approximately 20%. Tectorigenin (50 μM) induced Mn2+ influx suggesting of Ca2+ entry. Tectorigenin-induced Ca2+ entry was inhibited by 10% by three inhibitors of store-operated Ca2+ channels, namely, nifedipine, econazole, and SKF96365. In Ca2+-free medium, treatment with the endoplasmic reticulum Ca2+ pump inhibitor thapsigargin inhibited 83% of tectorigenin-evoked [Ca2+]i rises. Conversely, treatment with tectorigenin abolished thapsigargin-evoked [Ca2+]i rises. Inhibition of phospholipase C with U73122 inhibited 50% of tectorigenin-induced [Ca2+]i rises. Tectorigenin at concentrations between 10 and 60 μM killed cells in a concentration-dependent fashion. Chelation of cytosolic Ca2+ with 1,2-bis (2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid/acetoxy methyl did not reverse tectorigenin's cytotoxicity. Our data suggest that, in MDCK cells, tectorigenin evoked [Ca2+]i rises and induced cell death that was not associated with [Ca2+]i rises. Therefore, tectorigenin may be a Ca2+-independent cytotoxic agent for kidney cells.
Keywords: Ca2+ signal transduction, Madin-Darby Canine Kidney, tectorigenin, viability
|How to cite this article:|
Cheng HH, Liang WZ, Liao WC, Kuo CC, Hao LJ, Chou CT, Jan CR. Investigation of effect of tectorigenin (O-methylated isoflavone) on Ca2+ signal transduction and cytotoxic responses in canine renal tubular cells. Chin J Physiol 2020;63:60-7
|How to cite this URL:|
Cheng HH, Liang WZ, Liao WC, Kuo CC, Hao LJ, Chou CT, Jan CR. Investigation of effect of tectorigenin (O-methylated isoflavone) on Ca2+ signal transduction and cytotoxic responses in canine renal tubular cells. Chin J Physiol [serial online] 2020 [cited 2021 May 14];63:60-7. Available from: https://www.cjphysiology.org/text.asp?2020/63/2/60/283346
He-Hsiung Cheng, Wei-Zhe Liang and Wei-Chuan Liao contributed equally to this work.
| Introduction|| |
Tectorigenin, an isoflavoloid compound, is isolated from the dried flower of plants such as Pueraria thomsonii Benth.,, It is an O-methylated isoflavone, a type of flavonoid. The cellular action of tectorigenin includes modulation of adipogenic differentiation and adipocytokines secretion via peroxisome proliferator-activated receptor gamma and IκB kinase/nuclear factor-κB signaling pathways, suppression of the inflammation of lipopolysaccharide (LPS)-evoked acute lung injury in mice, repression of palmitate-caused endothelial insulin resistance via targeting reactive oxygen species-associated inflammation and insulin receptor substrate 1 pathway, enhancement of miR-338 expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis, and blockade of interferon-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells.
Regarding cancer research, tectorigenin has been shown to inhibit the inflammation-evoked epithelial-mesenchymal transition in a co-culture model of human lung carcinoma, sensitize paclitaxel-resistant human ovarian cancer cells, cause anti-proliferative on hepatic stellate cells, inhibit epidermal growth factor-induced activation of phospholipase C (PLC) proliferation in human epidermoid carcinoma cells, induce apoptosis in human promyelocytic leukemia HL-60 cells, and suppress osteosarcoma cell migration. Inin vivo studies, tectorigenin inhibited tumor growth in systemic malignancies. Besides cytotoxic effects in various models, the protective effect of tectorigenin on oxidative stress induced by hydrogen peroxide was shown. Tectorigenin also showed therapeutic effects on liver fibrosis in rats. However, the effect of tectorigenin on physiological responses in renal tubular cells is still unclear.
In terms of tectorigenin-induced Ca2+ signaling, tectorigenin was shown to evoke [Ca2+]i rises in HepG2 human hepatocellular carcinoma cells and isolated rat hepatocytes. However, these two studies did not explore the pathways underlying the Ca2+ signal. Ca2+ is a special cation in that it plays a key second messenger role in almost every cell type found. Many cell responses are triggered by a transient change in cytosolic-free Ca2+ levels ([Ca2+]i), such as contraction, fertilization, hormone and fluid secretion, muscle contraction, apoptosis, protein activation, and neural plasticity. In resting cells, [Ca2+]i is usually maintained at 50–100 nM. [Ca2+]i may rise via Ca2+ entry from extracellular solution and/or Ca2+ release from intracellular stores such as the endoplasmic reticulum, mitochondria, and lysosome., Several pathways are involved in Ca2+ influx such as receptors and Ca2+ channels including the store-operated Ca2+ entry channels., Activation of PLC can trigger the production of inositol 1, 4, 5-trisphosphate (IP3) that releases Ca2+ via the IP3 receptors on the endoplasmic reticulum membrane., Given the importance of Ca2+ signaling, it is crucial to unveil the pathways of the Ca2+ signal evoked by an agonist.
The aim of this study was to examine whether tectorigenin changed Ca2+ signal transduction and viability in Madin–Darby Canine Kidney (MDCK) renal tubular cells. The MDCK cells are commonly applied for kidney studies. Literature shows that [Ca2+]i rises can be induced in MDCK cells stimulated by various compounds such as angiotensin II, diindolylmethane, and thymol. The Ca2+-selective fluorescent dye fura-2 was applied as a probe to detect [Ca2+]i. The effect of tectorigenin on viability was measured by using water-soluble tetrazolium-1 (WST-1), a fluorescent indicator of mitochondrial activity.
| Materials and Methods|| |
Tectorigenin [Figure 1]a and other reagents were purchased from Sigma-Aldrich® (St. Louis, MO, USA) unless otherwise indicated. The reagents for cell culture were purchased from Gibco® (Gaithersburg, MD, USA). Aminopolycarboxylic acid/acetoxy methyl (fura-2/AM) and 1,2-bis (2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid/AM (BAPTA/AM) were purchased from Molecular Probes® (Eugene, OR, USA).
|Figure 1: Effect of tectorigenin (a) on [Ca2+]i in fura-2-loaded cells. (b) Tectorigenin was added at 25 s. The concentration of tectorigenin was indicated. The experiments were performed in Ca2+-containing medium. Y axis is the [Ca2+]i induced by tectorigenin in Ca2+-containing medium. (c) Effect of tectorigenin on [Ca2+]i in the absence of extracellular Ca2+. Tectorigenin was added at 25 s in Ca2+-free medium. Y axis is the [Ca2+]i rise induced by tectorigenin in Ca2+-free medium. (d) Concentration-response plots of tectorigenin-induced [Ca2+]i rises in the presence or absence of extracellular Ca2+. Y axis is the percentage of the net (baseline subtracted) area under the curve (25–250 s) of the [Ca2+]i rises induced by 50 µM tectorigenin in Ca2+-containing medium. Data are mean ± stand error of the mean of three independent experiments. *P < 0.05 compared to open circles.|
Click here to view
MDCK cells obtained from Bioresource Collection and Research Center (Taiwan) were cultured in minimum essential medium supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. Cells were maintained at 37°C in a humidified air containing 5% CO2.
Solutions used in [Ca2+]i measurements
Ca2+-containing medium (pH 7.4) had 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 5 mM glucose. Ca2+-free medium contained similar chemicals as Ca2+-containing medium except that CaCl2 was replaced with 0.3 mM ethylene glycol tetraacetic acid (EGTA) and 2 mM MgCl2. Tectorigenin was dissolved in absolute alcohol as a 0.1 M stock solution. The other chemicals were dissolved in water, ethanol, or dimethyl sulfoxide. The concentration of organic solvents in the experimental solutions did not exceed 0.1%, and did not affect viability or basal [Ca2+]i.
We measured [Ca2+]i abiding by protocols described previously.,, Confluent cells grown on 6-cm dishes were trypsinized and made into a suspension in culture medium at a concentration of 106 cell/ml. Cell viability was determined by trypan blue exclusion. The viability was >95% after the treatment. The cells were subsequently loaded with 2 μM fura-2/AM for 30 min at 25°C in the same medium. After loading, the cells were washed with Ca2+-containing medium twice and were made into a suspension in Ca2+-containing medium at a concentration of 107 cell/ml. Fura-2 fluorescence measurements were performed in a water-jacketed cuvette (25°C) with continuous stirring; the cuvette contained 1 ml of medium and 0.5 million cells. Fluorescence was monitored with a Shimadzu RF-5301PC spectrofluorophotometer immediately after 0.1 ml cell suspension was added to 0.9 ml Ca2+-containing or Ca2+-free medium, by recording excitation signals at 340 nm and 380 nm and emission signal at 510 nm at 1-s intervals. During the recording, reagents were added to the cuvette by pausing the recording for 2 s to open and close the cuvette-containing chamber. For calibration of [Ca2+]i, after completion of the experiments, the detergent Triton X-100 (0.1%) and CaCl2 (5 mM) were added to the cuvette to obtain the maximal fura-2 fluorescence. Then, the Ca2+ chelator EGTA (10 mM) was added to chelate Ca2+ in the cuvette to obtain the minimal fura-2 fluorescence. Control experiments showed that cells bathed in a cuvette had a viability of 95% after 20 min of fluorescence measurements. [Ca2+]i was calculated as previously described.
Mn2+ quenching of fura-2 fluorescence was performed in Ca2+-containing medium containing 50 μM MnCl2. MnCl2 was added to cell suspension in the cuvette 30 s before the fluorescence recoding was started. Data were recorded at an excitation signal at 360 nm (Ca2+-insensitive) and emission signal at 510 nm at 1-s intervals as described previously.
Cell viability analyses
The measurement of cell viability was based on the ability of cells to cleave tetrazolium salts by dehydrogenases. Increases in the amount of developed color correlated proportionally with the number of live cells. Assays were performed according to the manufacturer's instructions (Roche Molecular Biochemical, Indianapolis, IN, USA). The cells were seeded in 96-well plates at a density of 104 cell/well in culture medium for 24 h in the presence of tectorigenin. The cell viability detecting reagent 4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate] (WST-1; 10 μl pure solution) was added to samples after tectorigenin treatment, and the cells were incubated for 30 min in a humidified atmosphere. The cells were incubated with/without tectorigenin for 24 h. In the experiments using BAPTA/AM to chelate cytosolic Ca2+ to inhibit [Ca2+]i rises, the cells were treated with 5 μM BAPTA/AM for 1 h prior to incubation with tectorigenin. The cells were washed once with Ca2+-containing medium and incubated with/without tectorigenin for 24 h. The absorbance of samples (A450) was determined using a multiwall plate reader. Absolute optical density was normalized to the absorbance of unstimulated cells in each plate and expressed as a percentage of the control value. The absorbance of samples (A450) was determined using an enzyme-linked immunosorbent assay (ELISA) reader. Absolute optical density was normalized to the absorbance of unstimulated cells in each plate and expressed as a percentage of the control value.
Data were reported as mean ± standard error of the mean of three independent experiments. Data were analyzed by one-way analysis of variances using the Statistical Analysis System (SAS®, SAS Institute Inc., Cary, NC, USA). Multiple comparisons between group means were performed by post hoc analysis using the Tukey's honestly significantly difference procedure. P <0.05 was considered statistically significant.
| Results|| |
Effect of tectorigenin on [Ca2+]i in Madin-Darby Canine Kidney cells
[Figure 1]b shows that the basal [Ca2+]i level was 52 ± 2 nM. At 5–50 μM, tectorigenin induced concentration-dependent rises in [Ca2+]i. At a concentration of 50 μM, tectorigenin induced [Ca2+]i rises of 95 ± 5 nM. This signal was saturated at 50 μM because 100 μM tectorigenin did not induce a larger response (not shown). In Ca2+-free medium, tectorigenin also induced concentration-dependent rises in [Ca2+]i at 5–50 μM. At 50 μM, tectorigenin induced rises in [Ca2+]i of 71 ± 2 nM [Figure 1]c. [Figure 1]d shows the concentration–response relationship. The half-maximal effective concentration (EC50) value was 10 ± 2 μM in Ca2+-containing medium or 20 ± 3 μM in Ca2+-free medium, respectively, by fitting to a Hill equation. Ca2+ removal reduced the Ca2+ signal by approximately 20%. [Figure 1] shows that tectorigenin-induced Ca2+ response saturated at 50 μM; thus, 50 μM tectorigenin was used in the following experiments as control.
Tectorigenin-induced Mn2+ influx in Madin–Darby Canine Kidney cells
Further experiments were conducted to determine the role of Ca2+ influx in tectorigenin-induced [Ca2+]i rises. Evidence shows that Mn2+ and Ca2+ share similar movement pathways, however, it differs from Ca2+ by quenching fura-2 fluorescence at all excitation wavelengths. The fura-2 fluorescence at the excitation wavelength of 360 nm is insensitive to Ca2+, therefore, quenching of fura-2 fluorescence excited at 360 nm by Mn2+ suggests that Ca2+ influx occurs. [Figure 2] shows that 50 μM tectorigenin evoked an instant decrease in the 360 nm excitation signal that reached a maximum value of 101 ± 2 arbitrary units at 250 s.
|Figure 2: Effect of tectorigenin on Ca2+ influx by measuring Mn2+ quenching of fura-2 fluorescence. Experiments were performed in Ca2+-containing medium. MnCl2 (50 µM) was added to cells 1 min before fluorescence measurements. The y axis is fluorescence intensity (in arbitrary units) measured at the Ca2+-insensitive excitation wavelength of 360 nm and the emission wavelength of 510 nm. Trace a: Control, without tectorigenin. Trace b: Tectorigenin (50 µM) was added as indicated. Data are mean ± standard error of the mean of three independent experiments|
Click here to view
Regulation of tectorigenin-induced [Ca2+]i rises in Madin–Darby Canine Kidney cells
In Ca2+-containing medium, 1 min before addition of tectorigenin, phorbol 12-myristate 13 acetate (PMA; 1 nM; a protein kinase C (PKC) activator), GF109203X (2 μM; a PKC inhibitor), econazole (0.5 μM), nifedipine (1 μM), or SKF96365 (5 μM) was administered. All the chemicals except PMA and GF109203X inhibited tectorigenin-induced [Ca2+]i rises by approximately 10% [Figure 3].
|Figure 3: Effect of Ca2+ channel modulators on tectorigenin-induced [Ca2+]i rises. In blocker or modulator-treated groups, the reagent was added 1 min before tectorigenin (50 µM). The concentration was 1 µM for nifedipine, 0.5 µM for econazole, 5 µM for SKF96365, 10 nM for phorbol 12-myristate 13 acetate, and 2 µM for GF109203X. Data are expressed as the percentage of control (1st column) that is the area under the curve (25–200 s) of 50 µM tectorigenin-induced [Ca2+]i rises in Ca2+-containing medium, and are mean ± standard error of the mean of three independent experiments. *P < 0.05 compared to the 1st column|
Click here to view
Sources of tectorigenin-induced Ca2+ release in Madin–Darby Canine Kidney cells
Effort was made to examine the organelles responsible for tectorigenin-induced [Ca2+]i rises. Literature shows that the endoplasmic reticulum is a key Ca2+ store, in most cells. In the following experiments, the role of the endoplasmic reticulum in tectorigenin-evoked Ca2+ release in MDCK cells was explored. The experiments were conducted in Ca2+-free medium to prevent the interference of Ca2+ influx. [Figure 4]a shows that 1 μM thapsigargin, an endoplasmic reticulum Ca2+ pump inhibitor, induced [Ca2+]i rises of 40 ± 1 nM. Tectorigenin (50 μM) added at 500 s induced a small Ca2+ signal of 10 ± 2 nM. [Figure 4]b shows that tectorigenin (50 μM) induced [Ca2+]i rises of 55 ± 2 nM. Thapsigargin added at 500 s failed to induce [Ca2+]i rises. It appears that the endoplasmic reticulum played a pivotal role in tectorigenin-evoked Ca2+ release from organelles.
|Figure 4: Effect of thapsigargin on tectorigenin-induced Ca2+ release. (a and b) Thapsigargin (TG; 1 μM) and tectorigenin (50 μM) were added at time points indicated. Experiments were performed in Ca2+-free medium. Data are mean ± standard error of the mean of three independent experiments|
Click here to view
A role of phospholipase C in tectorigenin-induced [Ca2+]i rises in Madin–Darby Canine Kidney cells
PLC can activate the release of Ca2+ from the endoplasmic reticulum via IP3., Therefore, the role of PLC in tectorigenin-induced Ca2+ release was explored. The PLC inhibitor U73122 was applied to examine if the activation of PLC was needed for tectorigenin-induced Ca2+ release. [Figure 5]a shows that ATP (10 μM) induced [Ca2+]i rises of 41 ± 2 nM. ATP is a PLC-dependent agonist of [Ca2+]i rises in most cell types. [Figure 5]b shows that incubation with 2 μM U73122 did not change basal [Ca2+]i, but abolished ATP-induced [Ca2+]i rises. This suggests that U73122 effectively suppressed PLC activity. The data also show that incubation with 2 μM U73122 partly inhibited the combination of ATP and tectorigenin-induced [Ca2+]i rises by half. Furthermore, ATP and tectorigenin did not induce [Ca2+]i rises synergistically. The U73122 analog U73343 which does not have inhibition on PLC was used as control for U73122. Our findings suggest that U73343 (2 μM) did not change ATP-induced [Ca2+]i responses (not shown). It suggests that tectorigenin-induced Ca2+ release from the endoplasmic reticulum required PLC activation.
|Figure 5: Effect of U73122 on tectorigenin-induced Ca2+ release. Experiments were performed in Ca2+-free medium. (a) Adenosine triphosphate (10 μM) was added at 25 s. (b) The first column is 50 μM tectorigenin-induced [Ca2+]i rises. The second column shows that 2 μM U73122 did not alter basal [Ca2+]i. The third column shows ATP-induced [Ca2+]i rises. The fourth column shows that U73122 pretreatment for 60 s abolished ATP-induced [Ca2+]i rises (*P < 0.05 compared to 3rd column). The fifth column shows that U73122 (incubation for 60 s) and adenosine triphosphate (incubation for 30 s) pretreatment inhibited 50 μM tectorigenin-induced [Ca2+]i rises. The sixth column shows that combination of adenosine triphosphate (10 μM) tectorigenin (50 μM) did not induce [Ca2+]i rises synergistically. Data are mean ± standard error of the mean of three independent experiments|
Click here to view
Cytotoxic effect of tectorigenin on Madin–Darby Canine Kidney cells
Considering uncontrolled [Ca2+]i rises may change cell viability, experiments were conducted to explore the action of tectorigenin on the viability of MDCK cells. Cells were treated with 0–60 μM tectorigenin for 24 h, and the tetrazolium assay was performed. In the presence of 10–60 μM tectorigenin, cell viability decreased concentration dependently [Figure 6]. The IC50(half maximal inhibitory concentration) value of tectorigenin was approximately 45.5 μM in MDCK cells.
|Figure 6: Cytotoxic effect of tectorigenin. (a) Following 1,2-bis (2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid/acetoxy methyl (BAPTA/AM) treatment, cells were incubated with fura-2-acetoxy methyl as described in “Materials and methods.” Then, [Ca2+]i measurements were conducted in Ca2+-containing medium. Tectorigenin was added as indicated. (b) Cells were treated with 0–60 µM tectorigenin for 24 h, and cell viability assay was performed. Data are mean ± standard error of the mean of three independent experiments. Each treatment had six replicates (wells). Data are expressed as percentage of control response that is the increase in cell numbers in tectorigenin-free groups. Control had 10,545 ± 285 cells/well before experiments, and had 13852 ± 845 cells/well after incubation for 24 h. *P < 0.05 compared to control. In each group, the Ca2+ chelator BAPTA/AM (5 µM) was added to cells followed by treatment with tectorigenin in medium. Cell viability assay was subsequently performed.|
Click here to view
No effect of 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid/acetoxy methyl on preventing tectorigenin-evoked cell death
Question arose whether the tectorigenin-evoked cell death was induced by preceding [Ca2+]i responses. The intracellular Ca2+ chelator BAPTA/AM was widely appliedin vitro experiments to suppress [Ca2+]i rises. After treatment with 5 μM BAPTA/AM, tectorigenin (50 μM) did not evoke [Ca2+]i rises in BAPTA/AM-treated cells in both Ca2+-containing and Ca2+-free solutions [Figure 6]a. This suggests that BAPTA loading for 25 h still effectively chelated cytosolic Ca2+. [Figure 6]b also shows that 5 μM BAPTA/AM loading did not alter the control value of cell viability. In the presence of 10–60 μM tectorigenin, BAPTA/AM loading did not reverse tectorigenin-induced cell death.
| Discussion|| |
With regard to the effect of tectorigenin on [Ca2+]i, the literature is meager. Evidence shows that tectorigenin affected Ca2+ homeostasis in HepG2 cells and isolated rat hepatocytes. However, the underlying mechanisms were not clear. This study represents the first attempt to explore the effect of tectorigenin on Ca2+ signaling and viability in MDCK cells. Our study shows that tectorigenin increased [Ca2+]i in MDCK cells. The Ca2+ signal was composed of Ca2+ entry and Ca2+ release because the signal was reduced by 20% by removing extracellular Ca2+. The Mn2+ quenching data also suggest that Ca2+ influx occurred during tectorigenin incubation.
Our findings show that tectorigenin-evoked [Ca2+]i rises were inhibited by 10% by econazole, nifedipine, and SKF96365. These chemicals are often used to suppress store-operated Ca2+ entry.,, Our data suggest that tectorigenin-caused Ca2+ entry partly went through store-operated Ca2+ entry. Because 20% of tectorigenin-induced [Ca2+]i rises was via Ca2+ influx, this influx appears to involve store-operated Ca2+ entry and other unknown pathways. Studies have shown that in MDCK cells, three are some plasmamemmal cation channels that participate in Ca2+ signaling, including transient receptor potential channels. As selective blockers are still lacking for these channels, the pathways underlying tectorigenin-induced Ca2+ influx in MDCK cells deserve further investigation.
The interactive relationship between protein kinases and Ca2+ homeostasis has been established. For instance, atrial G protein-activated K+ channels activity was regulated by different Ca2+-dependent PKC isoforms in a receptor-specific manner. Fluvastatin was reported to inhibit Rab5-mediated slow delayed rectifier K+ currents (IKs) internalization caused by chronic Ca2+-dependent PKC activation. In contrast, Ca2+-independent PKC isoform was thought to be activatedin vitro andin vivo by ingenol 3,20 dibenzoate. Our data show that tectorigenin-evoked [Ca2+]i rises were not inhibited by enhancing or inhibiting PKC activity. This suggests that tectorigenin induced a PKC-independent [Ca2+]i signal.
The sesquiterpene lactone thapsigargin is found in the plant Thapsia garganica, and is one of the major constituents of the roots and fruits of this Mediterranean species. Thapsigargin has a strong inhibitory effect on the Ca2+ pump on the endoplasmic reticulum and is widely applied to study Ca2+ homeostasis. Our data suggest that the Ca2+ stores involved in tectorigenin-induced Ca2+ release appear to be the thapsigargin-sensitive endoplasmic reticulum store. However, thapsigargin did not completely inhibit tectorigenin-induced Ca2+ release, therefore, tectorigenin may also release Ca2+ from other stores such as lysosome and mitochondria.
The data further show that the Ca2+ release was via a PLC-dependent pathway because the release was suppressed by 50% when PLC activity was inhibited. A key mechanism that underlies the release of Ca2+ from the endoplasmic reticulum is through Ca2+ release via the IP3 receptors on the endoplasmic reticulum membrane., IP3 and diacylglycerol (DAG) are produced when phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma membrane is hydrolyzed by PLC. IP3 and DAG are crucial second messengers modulating different cellular responses. Therefore, it suggests that PLC activated by tectorigenin, an isoflavoloid compound, can trigger the production of IP3 that releases Ca2+ via the IP3 receptors on the endoplasmic reticulum membrane. As only half of tectorigenin-induced Ca2+ release was via PLC-associated pathways, other mechanisms might be involved such as the PLA2 pathways. For example, literature shows that agonist-mediated activation of PLA2 initiates Ca2+ mobilization in intestinal longitudinal smooth muscle in an IP3-independent manner.
Cell viability can be affected in a Ca2+-associated or Ca2+-dissociated fashion. Our data implicate that tectorigenin evoked cell death in a concentration-dependent, Ca2+-independent manner. As Ca2+ movement changes numerous cellular responses, tectorigenin may alter the physiology of MDCK cells in a Ca2+-dependent manner that awaits further investigation. Several studies were performed to explore the plasma level of tectorigenin in animal models. The plasma level of tectorigenin may reach ~10 μM., This level may be expected to go much higher in patients with liver or kidney disorders or taking higher doses., Our results suggest that tectorigenin at a concentration of 10 μM started to induce cell death and the IC50 was approximately 45.5 μM in MDCK cells. Thus, for some groups of kidney patients, our data may be clinically relevant.
Together, the results show that tectorigenin induced Ca2+ influx via PKC-insensitive store-operated Ca2+ entry and also Ca2+ release from the endoplasmic reticulum in a PLC-dependent manner. Tectorigenin also caused Ca2+-independent cell death. The effect of tectorigenin on [Ca2+]i and viability in MDCK cells should contribute to the pharmacology of tectorigenin. Our data may help otherin vitro researches to interpret their results because an alteration of [Ca2+]i may change many cellular responses.
This work was supported by RD-105001 from Chang Bing Show Chwan Memorial Hospital, Changhua County 50544, Taiwan.
Financial support and sponsorship
This work was supported by RD-105001 from Chang Bing Show Chwan Memorial Hospital, Changhua County 50544, Taiwan.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Liu B, Ma Y, Gao H, Wu Q. Tectorigenin monohydrate: An isoflavone from Belamcanda chinensis. Acta Crystallogr Sect E Struct Rep Online 2008;64:o2056.
Park KY, Jung GO, Choi J, Lee KT, Park HJ. Potent antimutagenic and their anti-lipid peroxidative effect of kaikasaponin III and tectorigenin from the flower of Pueraria thunbergiana. Arch Pharm Res 2002;25:320-4.
Ha le M, Que do TN, Huyen do TT, Long PQ, Dat NT. Toxicity, analgesic and anti-inflammatory activities of tectorigenin. Immunopharmacol Immunotoxicol 2013;35:336-40.
Li QY, Chen L, Yan MM, Shi XJ, Zhong MK. Tectorigenin regulates adipogenic differentiation and adipocytokines secretion via PPARγ and IKK/NF-κB signaling. Pharm Biol 2015;53:1567-75.
Ma CH, Liu JP, Qu R, Ma SP. Tectorigenin inhibits the inflammation of LPS-induced acute lung injury in mice. Chin J Nat Med 2014;12:841-6.
Wang Q, Cheng XL, Zhang DY, Gao XJ, Zhou L, Qin XY, et al
. Tectorigenin attenuates palmitate-induced endothelial insulin resistance via targeting ROS-associated inflammation and IRS-1 pathway. PLoS One 2013;8:e66417.
Zhang H, Liu X, Chen S, Wu J, Ye X, Xu L, et al
. Tectorigenin inhibits thein vitro
proliferation and enhances miR-338* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis. J Ethnopharmacol 2010;131:165-73.
Pan CH, Kim ES, Jung SH, Nho CW, Lee JK. Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells. Arch Pharm Res 2008;31:1447-56.
Amin A, Mokhdomi TA, Bukhari S, Wani SH, Wafai AH, Lone GN, et al
. Tectorigenin ablates the inflammation-induced epithelial-mesenchymal transition in a co-culture model of human lung carcinoma. Pharmacol Rep 2015;67:382-7.
Yang YI, Lee KT, Park HJ, Kim TJ, Choi YS, Shih IeM, et al
. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway. Carcinogenesis 2012;33:2488-98.
Wu JH, Wang YR, Huang WY, Tan RX. Anti-proliferative and pro-apoptotic effects of tectorigenin on hepatic stellate cells. World J Gastroenterol 2010;16:3911-8.
Imoto M, Shimura N, Umezawa K. Inhibition of epidermal growth factor-induced activation of phospholipase C by psi-tectorigenin. J Antibiot (Tokyo) 1991;44:915-7.
Lee KT, Sohn IC, Kim YK, Choi JH, Choi JW, Park HJ, et al
. Tectorigenin, an isoflavone of Pueraria thunbergiana Benth., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol Pharm Bull 2001;24:1117-21.
Guo Y, Chen YH, Cheng ZH, Ou-Yang HN, Luo C, Guo ZL. Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro
. Anticancer Drugs 2016;27:540-6.
Kapoor S. Tectorigenin and its inhibitory effects on tumor growth in systemic malignancies. Immunopharmacol Immunotoxicol 2013;35:533.
Kang KA, Lee KH, Chae S, Zhang R, Jung MS, Kim SY, et al
. Cytoprotective effect of tectorigenin, a metabolite formed by transformation of tectoridin by intestinal microflora, on oxidative stress induced by hydrogen peroxide. Eur J Pharmacol 2005;519:16-23.
Gao XX, Shi DH, Chen YX, Cui JT, Wang YR, Jiang CP, et al
. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Arch Pharm Res 2012;35:1479-93.
Jiang CP, Ding H, Shi DH, Wang YR, Li EG, Wu JH. Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells. World J Gastroenterol 2012;18:1753-64.
Tomonaga T, Mine T, Kojima I, Taira M, Hayashi H, Isono K. Isoflavonoids, genistein, psi-tectorigenin, and orobol, increase cytoplasmic free calcium in isolated rat hepatocytes. Biochem Biophys Res Commun 1992;182:894-9.
Berridge MJ. Elementary and global aspects of calcium signaling. J Physiol 1997;499:291-306.
Putney JW Jr. A model for receptor-regulated calcium entry. Cell Calcium 1986;7:1-2.
Clapham DE. Calcium signaling. Cell 1995;80:259-68.
Liu CP, Chou CT, Liang WZ, Cheng JS, Chang HT, Kuo DH, et al
. Pathways of [Ca2+
]i rise evoked by angiotensin II in MDCK renal tubular cells. J Recept Signal Transduct Res 2013;33:380-6.
Fang YC, Chou CT, Chi CC, Lin KL, Li YD, Cheng HH, et al
. Effect of diindolylmethane on Ca2+
homeostasis and viability in MDCK renal tubular cells. Hum Exp Toxicol 2013;32:344-53.
Chang HT, Chou CT, Liang WZ, Lu T, Kuo DH, Shieh P, et al
. Effects of thymol on Ca2+
homeostasis and apoptosis in MDCK renal tubular cells. Chin J Physiol 2014;57:90-8.
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+
indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
Merritt JE, Jacob R, Hallam TJ. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989;264:1522-7.
Thastrup O, Cullen PJ, Drøbak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+
stores by specific inhibition of the endoplasmic reticulum Ca2+
-ATPase. Proc Natl Acad Sci U S A 1990;87:2466-70.
Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 1991;266:23856-62.
Florenzano F, Viscomi MT, Mercaldo V, Longone P, Bernardi G, Bagni C, et al
. P2X2R purinergic receptor subunit mRNA and protein are expressed by all hypothalamic hypocretin/orexin neurons. J Comp Neurol 2006;498:58-67.
Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 1980;19:2396-404.
Carrillo C, Giraldo M, Cavia MM, Alonso-Torre SR. Effect of oleic acid on store-operated calcium entry in immune-competent cells. Eur J Nutr 2017;56:1077-84.
Dago CD, Maux PL, Roisnel T, Brigaudeau C, Bekro YA, Mignen O, et al
. Preliminary structure-activity relationship (SAR) of a novel series of pyrazole SKF-96365 analogues as potential store-operated calcium entry (SOCE) inhibitors. Int J Mol Sci 2018;19:E856.
Zhang J, Wier WG, Blaustein MP. Mg2+
blocks myogenic tone but not K+
-induced constriction: Role for SOCs in small arteries. Am J Physiol Heart Circ Physiol 2002;283:H2692-705.
Li Q, Montalbetti N, Wu Y, Ramos A, Raychowdhury MK, Chen XZ, et al
. Polycystin-2 cation channel function is under the control of microtubular structures in primary cilia of renal epithelial cells. J Biol Chem 2006;281:37566-75.
Niemeyer A, Rinne A, Kienitz MC. Receptor-specific regulation of atrial GIRK channel activity by different Ca2+
-dependent PKC isoforms. Cell Signal 2019;64:109418.
Parks XX, Ronzier E, O-Uchi J, Lopes CM. Fluvastatin inhibits Rab5-mediated IKs internalization caused by chronic Ca2+
-dependent PKC activation. J Mol Cell Cardiol 2019;129:314-25.
Racke FK, Baird M, Barth RF, Huo T, Yang W, Gupta N, et al
. Uniquein vitro
thrombopoietic activities of ingenol 3,20 dibenzoate, a Ca2+
-independent protein kinase C isoform agonist. PLoS One 2012;7:e51059-.
Andersen TB, López CQ, Manczak T, Martinez K, Simonsen HT. Thapsigargin–from Thapsia
L. to mipsagargin. Molecules 2015;20:6113-27.
Murthy KS, Kuemmerle JF, Makhlouf GM. Agonist-mediated activation of PLA2 initiates Ca2+
mobilization in intestinal longitudinal smooth muscle. Am J Physiol 1995;269:G93-102.
Im JY, Joo HJ, Han PL. Rapid disruption of cellular integrity of zinc-treated astroglia Is Regulated by p38 MAPK and Ca-dependent mechanisms. Exp Neurobiol 2011;20:45-53.
Lu T, Huang CC, Lu YC, Lin KL, Liu SI, Wang BW, et al
. Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: Dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3. Clin Exp Pharmacol Physiol 2009;36:297-303.
Shi Z, Zhang G, Zhao L, Wang S, Kano Y, Yuan D. Excretion of tectorigenin in rat urine orally administrated at different dosages by ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. Eur J Drug Metab Pharmacokinet 2015;40:255-66.
Wang S, Gong T, Lu J, Kano Y, Yuan D. Simultaneous determination of tectorigenin and its metabolites in rat plasma by ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013;933:50-8.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]